Home › Post-COVID Conditions (Long COVID) › Texas › Austin
Post-COVID Conditions (Long COVID) clinical trials in Austin, TX
3 studies for Post-COVID Conditions (Long COVID) are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.
RecruitingPhase 1Healthy volunteers welcome
- TrialMed Clinical Research Unit, Austin
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
RecruitingObservational studyHealthy volunteers welcome
- Dell Children's Medical Center of Central Texas, Austin
A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
RecruitingPhase 1
- GSK Investigational Site, Austin
About Post-COVID Conditions (Long COVID)
Anyone who had COVID-19 can have ongoing symptoms. Learn about post-COVID conditions (long COVID), including symptoms, diagnosis, treatments, and prevention.
More about Post-COVID Conditions (Long COVID) on MedlinePlus
Post-COVID Conditions (Long COVID) trials in other cities
- New York City, NY15 studies
- Houston, TX13 studies
- Boston, MA13 studies
- Baltimore, MD12 studies
- Chicago, IL11 studies
- Washington, DC10 studies
- San Francisco, CA8 studies
- Durham, NC8 studies
- Atlanta, GA8 studies
- San Diego, CA7 studies
- Los Angeles, CA6 studies
- Pittsburgh, PA6 studies
Other studies in Austin
- Non-Small Cell Lung Cancer30 studies
- Cancer (all types)20 studies
- Obesity20 studies
- Colorectal Cancer19 studies
- Metastatic Cancer19 studies
- Overweight18 studies
- Heart Failure18 studies
- Breast Cancer18 studies
- Ovarian Cancer17 studies
- Endometrial Cancer15 studies
- Prostate Cancer15 studies
- Depression14 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.